Literature DB >> 14728779

Evolutionary dynamics of escape from biomedical intervention.

Yoh Iwasa1, Franziska Michor, Martin A Nowak.   

Abstract

Viruses, bacteria, eukaryotic parasites, cancer cells, agricultural pests and other inconvenient animates have an unfortunate tendency to escape from selection pressures that are meant to control them. Chemotherapy, anti-viral drugs or antibiotics fail because their targets do not hold still, but evolve resistance. A major problem in developing vaccines is that microbes evolve and escape from immune responses. The fundamental question is the following: if a genetically diverse population of replicating organisms is challenged with a selection pressure that has the potential to eradicate it, what is the probability that this population will produce escape mutants? Here, we use multi-type branching processes to describe the accumulation of mutants in independent lineages. We calculate escape dynamics for arbitrary mutation networks and fitness landscapes. Our theory shows how to estimate the probability of success or failure of biomedical intervention, such as drug treatment and vaccination, against rapidly evolving organisms.

Entities:  

Mesh:

Year:  2003        PMID: 14728779      PMCID: PMC1691545          DOI: 10.1098/rspb.2003.2539

Source DB:  PubMed          Journal:  Proc Biol Sci        ISSN: 0962-8452            Impact factor:   5.349


  29 in total

1.  The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions.

Authors:  M Lipsitch; C T Bergstrom; B R Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.

Authors:  J L Casado; F Dronda; K Hertogs; R Sabido; A Antela; P Martí-Belda; P Dehertogh; S Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2001-01-20       Impact factor: 2.205

Review 3.  Bacterial evolution and the cost of antibiotic resistance.

Authors:  R E Lenski
Journal:  Int Microbiol       Date:  1998-12       Impact factor: 2.479

Review 4.  The rise and fall of antimicrobial resistance.

Authors:  M Lipsitch
Journal:  Trends Microbiol       Date:  2001-09       Impact factor: 17.079

5.  Research on resistance to cancer drug Gleevec.

Authors:  C L Sawyers
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

Review 6.  HIV chemotherapy.

Authors:  D D Richman
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

7.  Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters.

Authors:  G Chang; C B Roth
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

8.  Compensatory mutations, antibiotic resistance and the population genetics of adaptive evolution in bacteria.

Authors:  B R Levin; V Perrot; N Walker
Journal:  Genetics       Date:  2000-03       Impact factor: 4.562

9.  Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus.

Authors:  Joshua B Plotkin; Jonathan Dushoff; Simon A Levin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 10.  Progress and challenges for malaria vaccines.

Authors:  Thomas L Richie; Allan Saul
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

View more
  37 in total

Review 1.  Emergence and natural selection of drug-resistant prions.

Authors:  James Shorter
Journal:  Mol Biosyst       Date:  2010-04-27

2.  Quiescence: a mechanism for escaping the effects of drug on cell populations.

Authors:  Tomás Alarcón; Henrik Jeldtoft Jensen
Journal:  J R Soc Interface       Date:  2010-06-11       Impact factor: 4.118

Review 3.  Evolution of acquired resistance to anti-cancer therapy.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2014-03-25       Impact factor: 2.691

4.  Dynamics of targeted cancer therapy.

Authors:  Ivana Bozic; Benjamin Allen; Martin A Nowak
Journal:  Trends Mol Med       Date:  2012-05-15       Impact factor: 11.951

5.  Organism size promotes the evolution of specialized cells in multicellular digital organisms.

Authors:  M Willensdorfer
Journal:  J Evol Biol       Date:  2007-11-23       Impact factor: 2.411

6.  The fastest evolutionary trajectory.

Authors:  Arne Traulsen; Yoh Iwasa; Martin A Nowak
Journal:  J Theor Biol       Date:  2007-08-28       Impact factor: 2.691

Review 7.  The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.

Authors:  L Temime; G Hejblum; M Setbon; A J Valleron
Journal:  Epidemiol Infect       Date:  2007-09-04       Impact factor: 2.451

8.  Stochastic tunnels in evolutionary dynamics.

Authors:  Yoh Iwasa; Franziska Michor; Martin A Nowak
Journal:  Genetics       Date:  2004-03       Impact factor: 4.562

9.  Evolution of resistance to anti-cancer therapy during general dosing schedules.

Authors:  Jasmine Foo; Franziska Michor
Journal:  J Theor Biol       Date:  2009-12-11       Impact factor: 2.691

10.  Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies.

Authors:  Jasmine Foo; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2009-11-06       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.